Elon Musk’s Neuralink has been a trailblazer in brain chip implant technology. But today, rival company Precision Neuroscience announced that a core component of its brain implant system has been approved by the U.S. Food and Drug Administration.
Category: us food and drug administration
Auto Added by WPeMatico
Eli Lilly and Novo Nordisk are tackling heart health next
Target slashes bonuses, Walmart holds the eggs, and cheaper Wegovy: Business news roundup
Target has announced it will reduce bonuses for salaried employees due to weak consumer spending and inflationary pressures.
- Eli Lilly’s Alzheimer’s drug is rejected by EU regulators over brain swelling risk, despite U.S. approval
The European Union’s health regulator on Friday rejected Eli Lilly’s (LLY) Alzheimer’s drug, Kisunla, citing risks of brain swelling and bleeding. It’s a major setback for the company as it competes with a similar treatment from Biogen (BIIB) and Eisai.
Cheaper Wegovy, 23andMe shutters, and RFK Jr. cuts FDA jobs: Pharma news roundup
Novo Nordisk is expanding its cash-only savings program offering its blockbuster weight-loss drug Wegovy for $499 a month at all U.S. pharmacies. 23andMe has filed for Chapter 11 bankruptcy protection with CEO Anne Wojcicki stepping down to help with a sale. And the U.S. Department of Health and Human Services (HHS)…
- Eli Lilly’s online health platform just expanded beyond weight loss to tackle Alzheimer’s
- GLP-1s are driving returns on R&D investments for Big Pharma, report says
Big Pharma is expected to see big returns from its investment in a class of drugs made famous by Novo Nordisk’s (NVO) popular diabetes drug Ozempic.
